{"id":13631,"date":"2024-10-09T10:34:26","date_gmt":"2024-10-09T07:34:26","guid":{"rendered":"https:\/\/ozgurkilickesmez.com\/?p=13631"},"modified":"2025-12-12T14:56:18","modified_gmt":"2025-12-12T11:56:18","slug":"clasificarea-bethesda","status":"publish","type":"post","link":"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/","title":{"rendered":"Clasificarea Bethesda"},"content":{"rendered":"<p>Clasificarea Bethesda este un sistem standard de raportare care \u00eemparte rezultatele biopsiei cu aspira\u021bie cu ac fin (BAAF) a nodulilor tiroidieni \u00een \u0219ase categorii. Fiecare categorie este definit\u0103 \u00een func\u021bie de claritatea diagnostic\u0103 \u0219i riscul de malignitate, permi\u021b\u00e2nd astfel elaborarea corect\u0103 a planului de tratament.<\/p>\n<p>Sistemul Bethesda pentru nodulii tiroidieni cre\u0219te coeren\u021ba interpret\u0103rii \u00een rapoartele de patologie. Prin clase precum material insuficient, benign, atipie incert\u0103, suspiciune de neoplasm folicular, suspiciune de malignitate \u0219i malign, abordarea clinic\u0103 devine mai clar\u0103. Aceast\u0103 structur\u0103 reduce interven\u021biile chirurgicale inutile.<\/p>\n<p>\u00cen clasificarea Bethesda, \u00een categoriile cu risc sc\u0103zut este recomandat\u0103 supravegherea, \u00een timp ce \u00een grupurile cu risc mediu \u0219i ridicat se recomand\u0103 interven\u021bii chirurgicale sau investiga\u021bii diagnostice avansate. Astfel, devin posibile at\u00e2t diagnosticarea precoce, c\u00e2t \u0219i strategii eficiente de tratament.<\/p>\n<p>Versiunea actualizat\u0103 a sistemului a \u00eent\u0103rit procesele decizionale clinice prin reconfigurarea ratelor de risc. Aceast\u0103 abordare este de o importan\u021b\u0103 major\u0103 at\u00e2t pentru siguran\u021ba pacientului, c\u00e2t \u0219i pentru gestionarea multidisciplinar\u0103.<\/p>\n<table>\n<tbody>\n<tr>\n<td>Denumirea Clasific\u0103rii<\/td>\n<td>Clasificarea Bethesda<\/td>\n<\/tr>\n<tr>\n<td>Defini\u021bie<\/td>\n<td>Este un sistem standard de clasificare utilizat pentru a raporta rezultatele biopsiilor tiroidiene cu aspira\u021bie cu ac fin (BAAF) \u0219i pentru a determina riscul de cancer.<\/td>\n<\/tr>\n<tr>\n<td>Domenii de Utilizare<\/td>\n<td>Este utilizat pentru evaluarea patologic\u0103 a nodulilor tiroidieni, analiza riscului de cancer \u0219i luarea deciziilor privind tratamentul \u0219i monitorizarea.<\/td>\n<\/tr>\n<tr>\n<td>Categorii de Clasificare<\/td>\n<td>Clasificarea Bethesda este alc\u0103tuit\u0103 din \u0219ase categorii, fiecare clasificat\u0103 \u00een func\u021bie de riscul de cancer.<\/td>\n<\/tr>\n<tr>\n<td>Categorii \u0219i Descrieri<\/td>\n<td>1. Inadecvat\/Nediagnostic: E\u0219antion care nu con\u021bine suficiente celule (risc de cancer 1-4%);<\/p>\n<p>Benign: Leziune benign\u0103 (risc de cancer 0-3%);<\/p>\n<p>Atipie cu Semnifica\u021bie Nedeterminat\u0103 (AUS)\/Leziune Folicular\u0103: Incert (risc de cancer 5-15%);<\/p>\n<p>Neoplasm Folicular sau Suspiciune de Neoplasm Folicular: Suspiciune de tumor\u0103 folicular\u0103 (risc de cancer 15-30%);<\/p>\n<p>Suspiciune de Malignitate: Suspiciune de cancer (risc de cancer 60-75%);<\/p>\n<p>Malign: Diagnostic de cancer (97-99%).<\/td>\n<\/tr>\n<tr>\n<td>Metode de Tratament<\/td>\n<td>\u00cen func\u021bie de rezultat, se planific\u0103 monitorizarea, repetarea biopsiei, interven\u021bia chirurgical\u0103 sau tratamentul cu <a href=\"https:\/\/ozgurkilickesmez.com\/ro\/ce-este-iodul-la-ce-foloseste-necesarul-zilnic-si-beneficiile-iodului\/\">iod<\/a> radioactiv; \u00een categoriile cu risc sc\u0103zut se recomand\u0103 \u00een general monitorizarea, iar \u00een cele cu risc ridicat se prefer\u0103 tratamentul chirurgical.<\/td>\n<\/tr>\n<tr>\n<td>Avantaje<\/td>\n<td>Asigur\u0103 standardizarea diagnosticului, determin\u0103 riscul de cancer \u0219i previne interven\u021biile chirurgicale inutile, fiind un ghid \u00een planificarea tratamentului.<\/td>\n<\/tr>\n<tr>\n<td>Monitorizare \u0219i Urm\u0103rire<\/td>\n<td>Riscul de cancer este evaluat \u00een func\u021bie de categorie; \u00een leziunile benigne se poate face urm\u0103rire anual\u0103, iar \u00een cele cu risc ridicat, urm\u0103rirea postoperatorie este important\u0103.<\/td>\n<\/tr>\n<tr>\n<td>Relevan\u021b\u0103 Clinic\u0103<\/td>\n<td>Determin\u0103 \u00een mod fiabil riscul de cancer tiroidian, separ\u00e2nd nodulii cu risc sc\u0103zut de cei cu risc ridicat \u0219i oferind standardizare \u00een gestionarea pacientului.<\/td>\n<\/tr>\n<tr>\n<td>Boli Asociate<\/td>\n<td>Noduli tiroidieni, cancer tiroidian (papilar, folicular, medular), tiroidit\u0103 (precum Hashimoto), hiperplazie \u0219i alte boli tiroidiene.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\t<section class=\"section\" id=\"section_2076656635\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n\n<div class=\"row\"  id=\"row-1857809518\">\n\n\n\t<div id=\"col-1744026694\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:#1c58ef;\" >\n\t\t\t\n\t\t\t\n\n<div class=\"row\"  id=\"row-519621814\">\n\n\n\t<div id=\"col-221647052\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<div class=\"img has-hover border-gorsel x md-x lg-x y md-y lg-y\" id=\"image_1224565453\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img decoding=\"async\" width=\"1020\" height=\"1020\" src=\"https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-1024x1024.webp\" class=\"attachment-large size-large\" alt=\"Medic specialist \u00een Radiologie Interven\u021bional\u0103 \u0219i Neuroradiologie\" srcset=\"https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-1024x1024.webp 1024w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-300x300.webp 300w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-150x150.webp 150w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie.webp 1080w\" sizes=\"(max-width: 1020px) 100vw, 1020px\" title=\"\">\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_1224565453 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-221647052 > .col-inner {\n  border-radius: 20px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1005385165\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner dark\"  >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-2130283593\" class=\"text\">\n\t\t\n\n<p><strong>Prof. Dr. \u00d6zg\u00fcr KILI\u00c7KESMEZ<br \/><\/strong><span style=\"font-size: 65%;\"><em>Radiologie Interven\u021bional\u0103 \/ Neuroradiologie Interven\u021bional\u0103<\/em><\/span><\/p>\n\t\t\n<style>\n#text-2130283593 {\n  font-size: 1.25rem;\n}\n@media (min-width:550px) {\n  #text-2130283593 {\n    font-size: 2rem;\n  }\n}\n<\/style>\n\t<\/div>\n\t\n<p>Prof. Dr. K\u0131l\u0131\u00e7kesmez de\u021bine Certificatul de Competen\u021b\u0103 \u00een Radiologie din Turcia, Certificatul de Competen\u021b\u0103 \u00een Radiologie Interven\u021bional\u0103 din Turcia, Certificarea pentru tratamentul accidentului vascular cerebral \u0219i Certificatul European de Radiologie Interven\u021bional\u0103 (EBIR). \u00cen cariera sa academic\u0103, a c\u00e2\u0219tigat Premiul I Siemens pentru Radiologie \u00een 2008.<\/p>\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/\" class=\"button white lowercase hide-for-small\" style=\"border-radius:15px;\">\n\t\t<span>CV<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/oduller\/\" class=\"button white lowercase hide-for-small\" style=\"border-radius:15px;\">\n\t\t<span>Premii<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/www.google.com\/search?sa=X&#038;sca_esv=02ef9b5328b381af&#038;tbm=lcl&#038;q=Prof+%C3%96zg%C3%BCr+K%C4%B1l%C4%B1%C3%A7kesmez+Recenzii&#038;rflfq=1&#038;num=20\" class=\"button white lowercase hide-for-small\" style=\"border-radius:15px;\" target=\"_blank\" rel=\"noopener\">\n\t\t<span>Recenzii<\/span>\n\t<\/a>\n\n\n<div class=\"row show-for-small\"  id=\"row-781781921\">\n\n\n\t<div id=\"col-793308034\" class=\"col medium-6 small-6 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/\" class=\"button white lowercase expand\" style=\"border-radius:15px;\">\n\t\t<span>CV<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/akademik-makaleler\/\" class=\"button white lowercase expand\" style=\"border-radius:15px;\">\n\t\t<span>Articole<\/span>\n\t<\/a>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1299855660\" class=\"col medium-6 small-6 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/oduller\/\" class=\"button white lowercase expand\" style=\"border-radius:15px;\">\n\t\t<span>Premii<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/www.google.com\/search?sa=X&#038;sca_esv=02ef9b5328b381af&#038;tbm=lcl&#038;q=Prof+%C3%96zg%C3%BCr+K%C4%B1l%C4%B1%C3%A7kesmez+Recenzii&#038;rflfq=1&#038;num=20\" class=\"button white lowercase expand\" style=\"border-radius:15px;\" target=\"_blank\" rel=\"noopener\">\n\t\t<span>Recenzii<\/span>\n\t<\/a>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1005385165 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n@media (min-width:550px) {\n  #col-1005385165 > .col-inner {\n    margin: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1744026694 > .col-inner {\n  padding: 30px 30px 1px 30px;\n  border-radius: 20px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\n\t\t\n<style>\n#section_2076656635 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n<\/style>\n\t<\/section>\n\t\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_89 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Con\u021binutul articolului<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #ffffff;color:#ffffff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #ffffff;color:#ffffff\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Ce_Este_Clasificarea_Bethesda\" >Ce Este Clasificarea Bethesda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Ce_Categorii_Include_Sistemul_Bethesda_pentru_Citopatologia_Tiroidiana\" >Ce Categorii Include Sistemul Bethesda pentru Citopatologia Tiroidian\u0103?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#De_ce_Este_Important_Sistemul_Bethesda_in_Gestionarea_Clinica\" >De ce Este Important Sistemul Bethesda \u00een Gestionarea Clinic\u0103?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Cum_Afecteaza_Clasificarea_Bethesda_Rezultatele_Pacientilor\" >Cum Afecteaz\u0103 Clasificarea Bethesda Rezultatele Pacien\u021bilor?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Care_Sunt_Limitarile_si_Actualizarile_Sistemului_Bethesda\" >Care Sunt Limit\u0103rile \u0219i Actualiz\u0103rile Sistemului Bethesda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Intrebari_Frecvente\" >\u00centreb\u0103ri Frecvente<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#De_ce_se_foloseste_clasificarea_Bethesda_pentru_nodulii_tiroidieni\" >De ce se folose\u0219te clasificarea Bethesda pentru nodulii tiroidieni?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Cate_categorii_sunt_in_clasificarea_Bethesda\" >C\u00e2te categorii sunt \u00een clasificarea Bethesda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Cum_este_determinat_riscul_de_cancer_prin_clasificarea_Bethesda\" >Cum este determinat riscul de cancer prin clasificarea Bethesda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#La_ce_pacienti_este_necesara_repetarea_biopsiei_conform_clasificarii_Bethesda\" >La ce pacien\u021bi este necesar\u0103 repetarea biopsiei conform clasific\u0103rii Bethesda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#In_ce_stadii_este_luata_in_considerare_interventia_chirurgicala_conform_clasificarii_Bethesda\" >\u00cen ce stadii este luat\u0103 \u00een considerare interven\u021bia chirurgical\u0103 conform clasific\u0103rii Bethesda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Cum_se_aplica_clasificarea_Bethesda_la_gravide\" >Cum se aplic\u0103 clasificarea Bethesda la gravide?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Se_evalueaza_rezultatele_Bethesda_impreuna_cu_ecografia\" >Se evalueaz\u0103 rezultatele Bethesda \u00eempreun\u0103 cu ecografia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Poate_clasificarea_Bethesda_sa_dea_rezultate_gresite\" >Poate clasificarea Bethesda s\u0103 dea rezultate gre\u0219ite?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Cum_afecteaza_clasificarea_Bethesda_procesul_de_urmarire_a_nodulilor_tiroidieni\" >Cum afecteaz\u0103 clasificarea Bethesda procesul de urm\u0103rire a nodulilor tiroidieni?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/clasificarea-bethesda\/#Cum_imbunatateste_clasificarea_Bethesda_succesul_tratamentului_cancerului_tiroidian\" >Cum \u00eembun\u0103t\u0103\u021be\u0219te clasificarea Bethesda succesul tratamentului cancerului tiroidian?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Ce_Este_Clasificarea_Bethesda\"><\/span>Ce Este Clasificarea Bethesda?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Clasificarea Bethesda este un sistem standard utilizat pentru a evalua rezultatele biopsiei cu aspira\u021bie cu ac fin a nodulilor tiroidieni. Aceast\u0103 clasificare are ca scop reducerea incertitudinilor diagnostice \u0219i ghidarea procesului de tratament. Este compus\u0103 din \u0219ase categorii, fiecare indic\u00e2nd riscul de malignitate (cancer) \u0219i abordarea clinic\u0103 recomandat\u0103. Acest sistem ofer\u0103 un limbaj comun endocrinologilor \u0219i patologilor. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ce_Categorii_Include_Sistemul_Bethesda_pentru_Citopatologia_Tiroidiana\"><\/span>Ce Categorii Include Sistemul Bethesda pentru Citopatologia Tiroidian\u0103?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Sistemul Bethesda ofer\u0103 \u0219ase categorii pentru citopatologia tiroidian\u0103, fiecare fiind asociat\u0103 cu riscul de malignitate \u0219i recomand\u0103ri de gestionare. Datorit\u0103 acestei clasific\u0103ri, locul rezultatelor BAAF \u00een procesul de luare a deciziilor clinice este clarificat. Categoriile acoper\u0103 un spectru care variaz\u0103 de la e\u0219antioane nediagnostice p\u00e2n\u0103 la diagnostice clare de malignitate. <\/p>\n<ul>\n<li>Nediagnostic\/Inadecvat (Categoria I): \u00cen probele cu pu\u021bine celule sau acoperite de s\u00e2nge nu se poate stabili un diagnostic. Se recomand\u0103 repetarea BAAF. Riscul de malignitate este estimat la 5-10%.<\/li>\n<li>Benign (Categoria II): Include afec\u021biuni benigne precum nodulii coloidali \u0219i tiroidita. Riscul de malignitate este \u00eentre 0-3%. Este necesar\u0103 urm\u0103rirea clinic\u0103 dac\u0103 nodulul cre\u0219te.<\/li>\n<li>Atipie sau Leziune Folicular\u0103 de Semnifica\u021bie Nedeterminat\u0103 (AUS\/FLUS) (Categoria III): Include cazuri incerte cu risc de malignitate de 5-15%. Se recomand\u0103 \u00een general repetarea BAAF sau teste moleculare.<\/li>\n<li>Neoplasm Folicular sau Suspiciune de Neoplasm Folicular (Categoria IV): Se observ\u0103 celule foliculare omogene. Riscul de malignitate este de 15-30%. De obicei se recomand\u0103 lobectomia.<\/li>\n<li>Suspiciune de Malignitate (Categoria V): Indic\u0103 posibilitatea unor afec\u021biuni precum carcinomul tiroidian papilar sau medular. Riscul de malignitate este de 60-75% \u0219i este necesar\u0103 interven\u021bia chirurgical\u0103.<\/li>\n<li>Malign (Categoria VI): Include cazurile cu diagnostic clar de malignitate. Riscul de malignitate \u00een aceast\u0103 categorie variaz\u0103 \u00eentre 97-99%.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"De_ce_Este_Important_Sistemul_Bethesda_in_Gestionarea_Clinica\"><\/span>De ce Este Important Sistemul Bethesda \u00een Gestionarea Clinic\u0103?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Sistemul Bethesda joac\u0103 un rol vital \u00een gestionarea clinic\u0103 a nodulilor tiroidieni \u0219i ofer\u0103 un cadru standardizat de raportare. Acesta include \u0219ase categorii de diagnostic, fiecare asociat\u0103 cu un anumit risc de malignitate, iar aceste categorii influen\u021beaz\u0103 direct strategiile de gestionare clinic\u0103. Sistemul ghideaz\u0103 clinicianul \u00een privin\u021ba momentului \u00een care se recomand\u0103 supravegherea, repetarea BAAF sau interven\u021bia chirurgical\u0103. Mai jos sunt prezentate abord\u0103ri de gestionare recomandate pentru unele categorii: <\/p>\n<ul>\n<li>Categorie Bethesda II (Benign): Nodulii prezint\u0103 \u00een general un risc sc\u0103zut de malignitate, astfel \u00eenc\u00e2t doar supravegherea \u0219i ecografiile periodice sunt suficiente.<\/li>\n<li>Categorie Bethesda III (AUS\/FLUS): Nodulii din aceast\u0103 categorie prezint\u0103 un risc de malignitate de 10-30%. De obicei se recomand\u0103 repetarea BAAF sau o urm\u0103rire ecografic\u0103 strict\u0103. Dac\u0103 ace\u0219ti noduli prezint\u0103 anomalii la biopsiile repetate, se poate lua \u00een considerare interven\u021bia chirurgical\u0103.<\/li>\n<li>Categorie Bethesda IV (Suspiciune de Neoplasm Folicular): Nodulii au un risc de malignitate de aproximativ 15-30%, astfel \u00eenc\u00e2t se recomand\u0103 frecvent o interven\u021bie chirurgical\u0103 diagnostic\u0103 pentru excluderea riscului de malignitate.<\/li>\n<\/ul>\n\n\t<section class=\"section\" id=\"section_1472135614\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n\n<div class=\"row\"  id=\"row-1400324679\">\n\n\n\t<div id=\"col-1422395433\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner box-shadow-2\"  >\n\t\t\t\n\t\t\t\n\n<div class=\"row\"  id=\"row-173232076\">\n\n\n\t<div id=\"col-2047108392\" class=\"col whatsapp-alani hide-for-small medium-3 small-12 large-3\"  >\n\t\t\t\t<div class=\"col-inner box-shadow-2\" style=\"background-color:rgb(37, 211, 102);\" >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-1405293461\" class=\"text\">\n\t\t\n\n<p><a href=\"https:\/\/api.whatsapp.com\/send\/?phone=905405032303&amp;text=Bun\u0103%2C+v\u0103+contactez+de+pe+https%3A%2F%2Fozgurkilickesmez.com%2F&amp;type=phone_number&amp;app_absent=0\"><span style=\"color: #ffffff;\">WhatsApp 24\/7 <br \/>Apas\u0103 <\/span><span style=\"color: #ffffff;\">Aici!<\/span><\/a><\/p>\n\t\t\n<style>\n#text-1405293461 {\n  font-size: 1.5rem;\n  text-align: center;\n  color: rgb(255,255,255);\n}\n#text-1405293461 > * {\n  color: rgb(255,255,255);\n}\n<\/style>\n\t<\/div>\n\t\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2047108392 > .col-inner {\n  padding: 30px 0px 12px 0px;\n  margin: 0px 0px -31px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-317396913\" class=\"col show-for-small medium-3 small-12 large-3\"  >\n\t\t\t\t<div class=\"col-inner box-shadow-2\" style=\"background-color:rgb(37, 211, 102);\" >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-2879898202\" class=\"text\">\n\t\t\n\n<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/api.whatsapp.com\/send\/?phone=905405032303&amp;text=Bun\u0103%2C+v\u0103+contactez+de+pe+https%3A%2F%2Fozgurkilickesmez.com%2F&amp;type=phone_number&amp;app_absent=0\">Apas\u0103 aici pentru suport WhatsApp 24\/7!<\/a><\/span><\/p>\n\t\t\n<style>\n#text-2879898202 {\n  font-size: 1.25rem;\n  text-align: center;\n  color: rgb(255,255,255);\n}\n#text-2879898202 > * {\n  color: rgb(255,255,255);\n}\n@media (min-width:550px) {\n  #text-2879898202 {\n    font-size: 1.5rem;\n  }\n}\n<\/style>\n\t<\/div>\n\t\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-317396913 > .col-inner {\n  padding: 20px 0px 1px 0px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 100px;\n}\n@media (min-width:550px) {\n  #col-317396913 > .col-inner {\n    margin: 0px 0px -40px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-657870854\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner text-left\"  >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-width:0px 0px 0px 0px;margin:0px 0px 0px 0px;\">\n\t<\/div>\n\t\t\t\n\n<div class=\"row\"  id=\"row-2147072651\">\n\n\n\t<div id=\"col-109850618\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\n<div class=\"wpcf7 no-js\" id=\"wpcf7-f8836-o1\" lang=\"tr-TR\" dir=\"ltr\" data-wpcf7-id=\"8836\">\n<div class=\"screen-reader-response\"><p role=\"status\" aria-live=\"polite\" aria-atomic=\"true\"><\/p> <ul><\/ul><\/div>\n<form action=\"\/ro\/wp-json\/wp\/v2\/posts\/13631#wpcf7-f8836-o1\" method=\"post\" class=\"wpcf7-form init\" aria-label=\"Contact form\" novalidate=\"novalidate\" data-status=\"init\">\n<fieldset class=\"hidden-fields-container\"><input type=\"hidden\" name=\"_wpcf7\" value=\"8836\" \/><input type=\"hidden\" name=\"_wpcf7_version\" value=\"6.2.3\" \/><input type=\"hidden\" name=\"_wpcf7_locale\" value=\"tr_TR\" \/><input type=\"hidden\" name=\"_wpcf7_unit_tag\" value=\"wpcf7-f8836-o1\" \/><input type=\"hidden\" name=\"_wpcf7_container_post\" value=\"0\" \/><input type=\"hidden\" name=\"_wpcf7_posted_data_hash\" value=\"\" \/>\n<\/fieldset>\n<div class=\"sp-form\">\n\t<div class=\"col-row\">\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"text-340\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" autocomplete=\"name\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Nume\" value=\"\" type=\"text\" name=\"text-340\" \/><\/span>\n\t\t\t<\/p>\n\t\t<\/div>\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"tel-10\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-tel wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-tel\" autocomplete=\"name\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Telefon\" value=\"\" type=\"tel\" name=\"tel-10\" \/><\/span>\n\t\t\t<\/p>\n\t\t<\/div>\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"email-563\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email\" autocomplete=\"name\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"E-mail\" value=\"\" type=\"email\" name=\"email-563\" \/><\/span>\n\t\t\t<\/p>\n\t\t<\/div>\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><input class=\"wpcf7-form-control wpcf7-submit has-spinner\" type=\"submit\" value=\"TRIMITE\" \/>\n\t\t\t<\/p>\n\t\t<\/div>\n\t<\/div>\n<\/div><p style=\"display: none !important;\" class=\"akismet-fields-container\" data-prefix=\"_wpcf7_ak_\"><label>&#916;<textarea name=\"_wpcf7_ak_hp_textarea\" cols=\"45\" rows=\"8\" maxlength=\"100\"><\/textarea><\/label><input type=\"hidden\" id=\"ak_js_1\" name=\"_wpcf7_ak_js\" value=\"32\"\/><script>\ndocument.getElementById( \"ak_js_1\" ).setAttribute( \"value\", ( new Date() ).getTime() );\n<\/script>\n<\/p><div class=\"wpcf7-response-output\" aria-hidden=\"true\"><\/div>\n<\/form>\n<\/div>\n\n\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-109850618 > .col-inner {\n  margin: 0px 0px -60px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-2069597453\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-294531334\" class=\"text\">\n\t\t\n\n<p>*V\u0103 recomand\u0103m s\u0103 completa\u021bi toate c\u00e2mpurile pentru a primi cel mai bun r\u0103spuns posibil.<\/p>\n\t\t\n<style>\n#text-294531334 {\n  font-size: 0.85rem;\n  line-height: 1.5;\n}\n@media (min-width:550px) {\n  #text-294531334 {\n    line-height: 0.75;\n  }\n}\n<\/style>\n\t<\/div>\n\t\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2069597453 > .col-inner {\n  margin: 0px 0px -40px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-657870854 > .col-inner {\n  padding: 0px 0px 0px 0px;\n  margin: 0px 0px -20px 0px;\n}\n@media (min-width:550px) {\n  #col-657870854 > .col-inner {\n    padding: 20px 0px 0px 0px;\n    margin: 0px 0px -66px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1422395433 > .col-inner {\n  padding: 30px 10px 0px 10px;\n  border-radius: 30px;\n}\n@media (min-width:550px) {\n  #col-1422395433 > .col-inner {\n    padding: 0px 20px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1472135614 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n<\/style>\n\t<\/section>\n\t\n<h2><span class=\"ez-toc-section\" id=\"Cum_Afecteaza_Clasificarea_Bethesda_Rezultatele_Pacientilor\"><\/span>Cum Afecteaz\u0103 Clasificarea Bethesda Rezultatele Pacien\u021bilor?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Sistemul de clasificare Bethesda serve\u0219te drept un instrument important care influen\u021beaz\u0103 rezultatele pacien\u021bilor \u00een evalu\u0103rile citopatologice at\u00e2t pentru cancerul tiroidian, c\u00e2t \u0219i pentru cel cervical. Acest sistem clasific\u0103 riscul de malignitate al nodulilor tiroidieni \u0219i al leziunilor cervicale \u00eentr-o structur\u0103 clar\u0103 \u0219i ofer\u0103 ghidaj pentru gestionarea clinic\u0103. Astfel, optimizeaz\u0103 op\u021biunile de tratament, reduc\u00e2nd interven\u021biile inutile \u0219i \u00eembun\u0103t\u0103\u021bind rezultatele.<\/p>\n<p>\u00cen Contextul Cancerului Tiroidian:<\/p>\n<p>Sistemul Bethesda pentru Raportarea Citopatologiei Tiroidiene (TBSRTC) clasific\u0103 \u00een \u0219ase categorii, fiecare purt\u00e2nd un anumit risc de malignitate:<\/p>\n<ul>\n<li>Categoria I: Nediagnostic\u0103\/insuficient\u0103; risc de malignitate 0-5%.<\/li>\n<li>Categoria II: Benign\u0103; risc de malignitate 0-3%.<\/li>\n<li>Categoria III: Leziune Folicular\u0103 Atipic\u0103\/Importan\u021b\u0103 Nedeterminat\u0103 (AUS\/FLUS); risc 10-30%.<\/li>\n<li>Categoria IV: Suspiciune de Neoplasm Folicular; risc 25-40%.<\/li>\n<li>Categoria V: Suspiciune de Malignitate; risc 50-75%.<\/li>\n<li>Categoria VI: Malign\u0103; risc de malignitate 97-99%.<\/li>\n<\/ul>\n<p> Aceste categorii ghideaz\u0103 \u00een mod special interven\u021biile precum chirurgia \u00een cazurile cu risc ridicat, \u00een timp ce pentru categoriile III \u0219i IV se recomand\u0103 biopsia repetat\u0103.<\/p>\n\n\t<section class=\"section dark\" id=\"section_1127247354\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\r\n\r\n\t<div id=\"gap-1458284218\" class=\"gap-element clearfix hide-for-medium\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1458284218 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\r\n\r\n<div class=\"row align-middle\"  id=\"row-412357269\">\r\n\r\n\n\t<div id=\"col-1090109717\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\r\n\r\n\t<div id=\"text-2530534920\" class=\"text\">\n\t\t\r\n\r\n<div><strong>Contacteaz\u0103-l acum pe Prof. Dr. \u00d6zg\u00fcr K\u0131l\u0131\u00e7kesmez pentru informa\u021bii detaliate \u0219i pentru a programa o consulta\u021bie!<\/strong><\/div>\r\n\t\t\n<style>\n#text-2530534920 {\n  font-size: 1.25rem;\n  text-align: center;\n}\n@media (min-width:550px) {\n  #text-2530534920 {\n    font-size: 1.15rem;\n  }\n}\n@media (min-width:850px) {\n  #text-2530534920 {\n    font-size: 1.5rem;\n    text-align: left;\n  }\n}\n<\/style>\n\t<\/div>\n\t\r\n\r\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1090109717 > .col-inner {\n  padding: 20px 0px 0px 0px;\n  margin: 0px 0px -10px 0px;\n}\n@media (min-width:550px) {\n  #col-1090109717 > .col-inner {\n    padding: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\r\n\n\t<div id=\"col-1399727790\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\r\n\r\n<a href=\"https:\/\/api.whatsapp.com\/send\/?phone=905405032303&#038;text=Bun\u0103%2C+v\u0103+contactez+de+pe+https%3A%2F%2Fozgurkilickesmez.com%2F&#038;type=phone_number&#038;app_absent=0\" target=\"_blank\" class=\"button alert is-small box-shadow-5\" rel=\"noopener\" style=\"border-radius:10px;padding:5px 20px 5px 20px;\">\n\t\t<span>Contact prin Whatsapp<\/span>\n\t<i class=\"icon-whatsapp\" aria-hidden=\"true\"><\/i><\/a>\n\r\n\r\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1399727790 > .col-inner {\n  padding: 20px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\r\n\r\n<\/div>\r\n\r\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1127247354 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n  background-color: #396cf0;\n}\n<\/style>\n\t<\/section>\n\t\r\n\t<div id=\"gap-328354341\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-328354341 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\r\n\n<h2><span class=\"ez-toc-section\" id=\"Care_Sunt_Limitarile_si_Actualizarile_Sistemului_Bethesda\"><\/span>Care Sunt Limit\u0103rile \u0219i Actualiz\u0103rile Sistemului Bethesda?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Limit\u0103rile \u0219i actualiz\u0103rile sistemului Bethesda includ revizuiri importante menite s\u0103 creasc\u0103 acurate\u021bea diagnostic\u0103 \u00een citopatologie. \u00cen primul r\u00e2nd, variabilitatea \u00een interpretare este una dintre limit\u0103rile majore ale sistemului Bethesda. \u00cen special \u00een citologia cervical\u0103 (ASC-US) \u0219i citopatologia tiroidian\u0103 (AUS), se observ\u0103 varia\u021bii \u00eentre observatori \u00een interpretarea cazurilor complexe. Aceast\u0103 variabilitate poate duce la rezultate diagnostice inconsistene \u00eentre laboratoare \u0219i poate \u00eengreuna deciziile de gestionare clinic\u0103.<\/p>\n<p>De asemenea, limit\u0103rile morfologice ale sistemului trebuie luate \u00een considerare. Sistemul Bethesda se bazeaz\u0103 \u00een mare m\u0103sur\u0103 pe interpretarea morfologic\u0103, ceea ce poate duce la diferen\u021be subiective. Actualiz\u0103rile din 2014 pentru citologia cervical\u0103 \u0219i din 2023 pentru citopatologia tiroidian\u0103 au integrat teste moleculare pentru a cre\u0219te acurate\u021bea diagnostic\u0103. Utilizarea testelor moleculare \u00een cazurile limit\u0103 \u0219i incerte urm\u0103re\u0219te s\u0103 reduc\u0103 aceste limit\u0103ri morfologice.<\/p>\n<p>Actualiz\u0103rile din Sistemul Bethesda includ:<\/p>\n<p>Actualiz\u0103rile din 2023 pentru Citopatologia Tiroidian\u0103:<\/p>\n<ul>\n<li aria-level=\"1\">Au fost introdu\u0219i markeri moleculari pentru AUS \u0219i leziuni foliculare.<\/li>\n<li aria-level=\"1\">Clasificarea atipiei arhitecturale \u0219i nucleare cu profiluri moleculare a fost implementat\u0103.<\/li>\n<li aria-level=\"1\">Au fost prezentate recomand\u0103ri pentru nodulii incerti pe baza constat\u0103rilor moleculare.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Intrebari_Frecvente\"><\/span>\u00centreb\u0103ri Frecvente<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"De_ce_se_foloseste_clasificarea_Bethesda_pentru_nodulii_tiroidieni\"><\/span>De ce se folose\u0219te clasificarea Bethesda pentru nodulii tiroidieni?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Clasificarea Bethesda este utilizat\u0103 pentru standardizarea rezultatelor biopsiei cu aspira\u021bie cu ac fin tiroidian. Astfel, se evalueaz\u0103 riscul de cancer al nodulilor \u0219i se stabile\u0219te planul de tratament.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Cate_categorii_sunt_in_clasificarea_Bethesda\"><\/span>C\u00e2te categorii sunt \u00een clasificarea Bethesda?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aceast\u0103 clasificare con\u021bine \u0219ase categorii diferite. Fiecare categorie este clasificat\u0103 \u00een func\u021bie de probabilitatea ca nodulul s\u0103 fie benign, incert sau malign, iar abordarea este adaptat\u0103 pacientului.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Cum_este_determinat_riscul_de_cancer_prin_clasificarea_Bethesda\"><\/span>Cum este determinat riscul de cancer prin clasificarea Bethesda?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fiecare categorie implic\u0103 un risc diferit de cancer. De exemplu, \u00een Bethesda II riscul este foarte sc\u0103zut, iar \u00een Bethesda V \u0219i VI probabilitatea de malignitate este mare. Aceste rate ghideaz\u0103 decizia chirurgical\u0103.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"La_ce_pacienti_este_necesara_repetarea_biopsiei_conform_clasificarii_Bethesda\"><\/span>La ce pacien\u021bi este necesar\u0103 repetarea biopsiei conform clasific\u0103rii Bethesda?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>\u00cen categoriile Bethesda I (nediagnostic) \u0219i Bethesda III (atipie de semnifica\u021bie incert\u0103) se poate recomanda repetarea biopsiei pentru un diagnostic clar. Astfel, se reduce \u0219ansa unui diagnostic gre\u0219it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"In_ce_stadii_este_luata_in_considerare_interventia_chirurgicala_conform_clasificarii_Bethesda\"><\/span>\u00cen ce stadii este luat\u0103 \u00een considerare interven\u021bia chirurgical\u0103 conform clasific\u0103rii Bethesda?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Interven\u021bia chirurgical\u0103 este \u00een general inevitabil\u0103 \u00een categoriile Bethesda V (suspiciune de malignitate) \u0219i VI (malign). \u00cen Bethesda IV, riscul fiind moderat, chirurgia este adesea preferat\u0103.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Cum_se_aplica_clasificarea_Bethesda_la_gravide\"><\/span>Cum se aplic\u0103 clasificarea Bethesda la gravide?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Nodulii tiroidieni la gravide sunt evalua\u021bi conform clasific\u0103rii Bethesda. Totu\u0219i, decizia chirurgical\u0103 este planificat\u0103 cu mai mult\u0103 precau\u021bie, \u00een func\u021bie de stadiul sarcinii \u0219i riscul estimat.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Se_evalueaza_rezultatele_Bethesda_impreuna_cu_ecografia\"><\/span>Se evalueaz\u0103 rezultatele Bethesda \u00eempreun\u0103 cu ecografia?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Da, caracteristicile ecografice ale nodulului sunt analizate \u00eempreun\u0103 cu rezultatul biopsiei. Dac\u0103 ecografia indic\u0103 semne suspecte, se pot recomanda investiga\u021bii suplimentare chiar \u0219i \u00een categoriile Bethesda joase.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Poate_clasificarea_Bethesda_sa_dea_rezultate_gresite\"><\/span>Poate clasificarea Bethesda s\u0103 dea rezultate gre\u0219ite?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Experien\u021ba \u00een efectuarea biopsiei, calitatea probei \u0219i structura nodulului pot influen\u021ba rezultatul. Prin urmare, trebuie evaluat\u0103 \u00eentotdeauna \u00eempreun\u0103 cu datele clinice, de laborator \u0219i imagistice.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Cum_afecteaza_clasificarea_Bethesda_procesul_de_urmarire_a_nodulilor_tiroidieni\"><\/span>Cum afecteaz\u0103 clasificarea Bethesda procesul de urm\u0103rire a nodulilor tiroidieni?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>\u00cen categoriile Bethesda cu risc sc\u0103zut, se fac monitoriz\u0103ri regulate prin ecografie \u0219i teste hormonale, \u00een timp ce \u00een grupurile cu risc ridicat se acord\u0103 prioritate interven\u021biei chirurgicale sau investiga\u021biilor avansate. Acest sistem permite personalizarea tratamentului.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Cum_imbunatateste_clasificarea_Bethesda_succesul_tratamentului_cancerului_tiroidian\"><\/span>Cum \u00eembun\u0103t\u0103\u021be\u0219te clasificarea Bethesda succesul tratamentului cancerului tiroidian?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Deoarece riscul de cancer este clar definit, se evit\u0103 interven\u021biile chirurgicale inutile, iar \u0219ansele de interven\u021bie timpurie cresc. Aceast\u0103 abordare ofer\u0103 un avantaj important at\u00e2t pentru siguran\u021ba pacientului, c\u00e2t \u0219i pentru succesul tratamentului.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clasificarea Bethesda este un sistem standard de raportare care \u00eemparte rezultatele biopsiei cu aspira\u021bie cu ac fin (BAAF) a nodulilor tiroidieni \u00een \u0219ase categorii. Fiecare categorie este definit\u0103 \u00een func\u021bie de claritatea diagnostic\u0103 \u0219i riscul de malignitate, permi\u021b\u00e2nd astfel elaborarea corect\u0103 a planului de tratament. Sistemul Bethesda pentru nodulii tiroidieni cre\u0219te coeren\u021ba interpret\u0103rii \u00een rapoartele [&#8230;]\n","protected":false},"author":2,"featured_media":13630,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[359],"tags":[],"class_list":["post-13631","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts\/13631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/comments?post=13631"}],"version-history":[{"count":2,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts\/13631\/revisions"}],"predecessor-version":[{"id":13675,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts\/13631\/revisions\/13675"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/media\/13630"}],"wp:attachment":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/media?parent=13631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/categories?post=13631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/tags?post=13631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}